• 1
    Hermaszewski RA, Webster D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86:3142.
  • 2
    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:3448.
  • 3
    Stiehm ER, Chin TW, Haas A, Peerless AG. Infectious complications of the primary immunodeficiencies. Clin Immunol Immunopathol 1986; 40:6986.
  • 4
    Webster ADB. Common variable immunodeficiency. In: RoifmannC, ed. Humoral immunodeficiences. Immunol Allergy Clin North Am 2001;21:121.
  • 5
    Sideras P, Smith CI. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995; 59:135223.
  • 6
    Farrant J, Spickett G, Matamoros N et al. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). Immunodeficiency 1994; 5:15969.
  • 7
    Bayry J, Lacroix-Desmazes S, Kazatchkine MD et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004; 104:24413.
  • 8
    Scott-Taylor TH, Green MRJ, Eren E, Webster AD. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 2004; 138:48490.
  • 9
    Cunningham-Rundles C, Radigan L. Deficient IL-12 and dendritic cell function in common variable immunodeficiency. Clin Immunol 2005; 115:14753.
  • 10
    Wright JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990; 7:204651.
  • 11
    McQuaid A, Tormey VJ, Trafford B, Webster AD, Bofill M. Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency. Clin Exp Immunol 2003; 134:3217.
  • 12
    Aukrust P, Aandahl EM, Skalhegg BS et al. Increased activation of protein kinase A type 1 contributes to the T cell deficiency in common variable immunodeficiency. J Immunol 1999; 162:117885.
  • 13
    Jaffe JS, Strober W, Sneller MC. Functional characterisation of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 1993; 82:192201.
  • 14
    Serrano D, Becker K, Cunningham-Rundles C, Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8+ T cells. Clin Immunol 2000; 97:24858.
  • 15
    Wang ECY, Moss PAH, Frodsham P et al. CD8high CD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995; 155:504656.
  • 16
    Chapel H, Geha R, Rosen F, IUIS PID (Primary Immunodeficiency) Classification Committee. Primary immunodeficiency diseases: an update. Clin Exp Immunol 2003; 132:915.
  • 17
    Currier JR, Kuta EG, Turk E et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial; ELISPOT assays. J Immunol Meth 2002; 260:15772.
  • 18
    Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation 1993; 56:86771.
  • 19
    Hislop AD, Gudgeon NH, Callan MFC et al. EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol 2001; 167:201929.
  • 20
    Appay V, Dunbar PR, Callan M et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:37985.
  • 21
    Sylwester AW, Mitchell BL, Edgar JB et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202:67385.
  • 22
    Khan NN, Shariff M, Cobbold R et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169:198492.
  • 23
    Wheat WH, Cool CD, Morimoto Y et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005; 202:47984.
  • 24
    Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35:12449.
  • 25
    Desrosiers M-P, Kielczewska A, Loredo-Osti J-C et al. Epistasis between mouse Klra and major histocompatibility complex class 1 loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 2005; 37:5939.
  • 26
    Iversen A-C, Norris PS, Ware CF, Benedict CA. Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-β. J Immunol 2005; 175:756874.
  • 27
    Bachmann MF, Hunziker L, Zinkernagel RM, Storni T, Kopf M. Maintenance of memory CTL responses by T helper cells and CD40–CD40 ligand: antibodies provide the key. Eur J Immunol 2004; 34:31726.
  • 28
    Khan N, Hislop A, Gudgeon N et al. Herpes virus specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to coresident EBV infection. J Immunol 2004; 173:74819.